ResearcherNational Institute for Health and Care ResearchActive in the last 2 years
Animesh Acharjee
Matched on ORCID iD 0000-0003-2735-7010; OpenAlex author ID A5008573021. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 2, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 13
2021: 1 paper · 2022: none · 2023: 2 papers · 2024: 3 papers · 2025: none · 2026: 2 papers
Papers 8
- Linking Targeted Pancreatic Cancer Genes With Metabolic Disorders: A Cross-Species Translational Pathway. Last author DOI 10.1002/cam4.71775↗
- RNF43 Mutations Are Associated With the Classical Molecular Subtype, Vigorous Antitumor Immune Responses, and Prolonged Survival in Pancreatic Adenocarcinoma. Co-author DOI 10.1016/j.modpat.2026.101010↗
- Network dynamics and therapeutic aspects of mRNA and protein markers with the recurrence sites of pancreatic cancer. Co-author DOI 10.1016/j.heliyon.2024.e31437↗
- Spatial Heterogeneity of Immune Regulators Drives Dynamic Changes in Local Immune Responses, Affecting Disease Outcomes in Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-24-0368↗
- High hypoxia status in pancreatic cancer is associated with multiple hallmarks of an immunosuppressive tumor microenvironment. First author DOI 10.3389/fimmu.2024.1360629↗
- Role of microbiota and microbiota-derived short-chain fatty acids in PDAC. Last author DOI 10.1002/cam4.5323↗
- Spatially restricted tumour-associated and host-associated immune drivers correlate with the recurrence sites of pancreatic cancer. Co-author DOI 10.1136/gutjnl-2022-329371↗
- Distinct Stromal and Immune Features Collectively Contribute to Long-Term Survival in Pancreatic Cancer. First author DOI 10.3389/fimmu.2021.643529↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Beat Gloor · 4 shared papers, 2021–2026 · strength 0.91
- Paper RNF43 Mutations Are Associated With the Classical Molecular Subtype, Vigorous Antitumor Immune Responses, and Prolonged… DOI 10.1016/j.modpat.2026.101010↗
- Paper Spatial Heterogeneity of Immune Regulators Drives Dynamic Changes in Local Immune Responses, Affecting Disease Outcomes… DOI 10.1158/1078-0432.ccr-24-0368↗
- Paper Spatially restricted tumour-associated and host-associated immune drivers correlate with the recurrence sites of pancre… DOI 10.1136/gutjnl-2022-329371↗
- Eva Karamitopoulou · 4 shared papers, 2021–2026 · strength 0.91
- Paper RNF43 Mutations Are Associated With the Classical Molecular Subtype, Vigorous Antitumor Immune Responses, and Prolonged… DOI 10.1016/j.modpat.2026.101010↗
- Paper Spatial Heterogeneity of Immune Regulators Drives Dynamic Changes in Local Immune Responses, Affecting Disease Outcomes… DOI 10.1158/1078-0432.ccr-24-0368↗
- Paper Spatially restricted tumour-associated and host-associated immune drivers correlate with the recurrence sites of pancre… DOI 10.1136/gutjnl-2022-329371↗
- Anna Silvia Wenning · 3 shared papers, 2023–2026 · strength 0.77
- Paper RNF43 Mutations Are Associated With the Classical Molecular Subtype, Vigorous Antitumor Immune Responses, and Prolonged… DOI 10.1016/j.modpat.2026.101010↗
- Paper Spatial Heterogeneity of Immune Regulators Drives Dynamic Changes in Local Immune Responses, Affecting Disease Outcomes… DOI 10.1158/1078-0432.ccr-24-0368↗
- Paper Spatially restricted tumour-associated and host-associated immune drivers correlate with the recurrence sites of pancre… DOI 10.1136/gutjnl-2022-329371↗
- Aurel A. Perren · 3 shared papers, 2023–2026 · strength 0.77
- Paper RNF43 Mutations Are Associated With the Classical Molecular Subtype, Vigorous Antitumor Immune Responses, and Prolonged… DOI 10.1016/j.modpat.2026.101010↗
- Paper Spatial Heterogeneity of Immune Regulators Drives Dynamic Changes in Local Immune Responses, Affecting Disease Outcomes… DOI 10.1158/1078-0432.ccr-24-0368↗
- Paper Spatially restricted tumour-associated and host-associated immune drivers correlate with the recurrence sites of pancre… DOI 10.1136/gutjnl-2022-329371↗
- Pauline Aeschbacher · 3 shared papers, 2023–2026 · strength 0.77
- Paper RNF43 Mutations Are Associated With the Classical Molecular Subtype, Vigorous Antitumor Immune Responses, and Prolonged… DOI 10.1016/j.modpat.2026.101010↗
- Paper Spatial Heterogeneity of Immune Regulators Drives Dynamic Changes in Local Immune Responses, Affecting Disease Outcomes… DOI 10.1158/1078-0432.ccr-24-0368↗
- Paper Spatially restricted tumour-associated and host-associated immune drivers correlate with the recurrence sites of pancre… DOI 10.1136/gutjnl-2022-329371↗
- Dipanwita Nath · 2 shared papers, 2024–2026 · strength 0.64
- Georgios V. Gkoutos · 2 shared papers, 2023–2024 · strength 0.50
- Hassan Sadozai · 2 shared papers, 2021–2024 · strength 0.41
- Paper High hypoxia status in pancreatic cancer is associated with multiple hallmarks of an immunosuppressive tumor microenvir… DOI 10.3389/fimmu.2024.1360629↗
- Paper Distinct Stromal and Immune Features Collectively Contribute to Long-Term Survival in Pancreatic Cancer. DOI 10.3389/fimmu.2021.643529↗
- Shivan Sivakumar · 1 shared paper, 2026 · strength 0.36
- Konstantin Bräutigam · 1 shared paper, 2026 · strength 0.33
- Bernard Burke · 1 shared paper, 2024 · strength 0.26
- Hülya YILMAZ TEMEL · 1 shared paper, 2023 · strength 0.22
- Mirjam Schenk · 1 shared paper, 2021 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.